Nektar enters quiet period ahead of REZOLVE-AA follow-up data
Nektar said its quiet period began Sept. 8, 2026, ahead of 24-week off-treatment follow-up data from the Phase 2b REZOLVE-AA study of rezpegaldesleukin.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.